Ocugen (OCGN) said interim data from phase 2/3 trial of Covaxin, developed by India's Bharat Biotech, was published in a journal and mentioned that the COVID-19 vaccine showed efficacy.
Our morgues are full : Zimbabwe struggles with surge in Covid burials thezimbabwemail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thezimbabwemail.com Daily Mail and Mail on Sunday newspapers.